Back
Merck & 10K Form
Buy
73
MRK
Merck &
Last Price:
106.26
Seasonality Move:
1.3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2010-03-30 | 10K | MRK/Merck & Annual |
| 2009-11-02 | 10Q | MRK/Merck & Quarterly |
| 2009-08-03 | 10Q | MRK/Merck & Quarterly |
| 2009-05-04 | 10Q | MRK/Merck & Quarterly |
| 2009-02-27 | 10K | MRK/Merck & Annual |
| 2008-11-03 | 10Q | MRK/Merck & Quarterly |
Receive MRK News And Ratings
See the #1 stock for the next 7 days that we like better than MRK
MRK Financial Statistics
Sales & Book Value
| Annual Sales: | $59.28B |
|---|---|
| Cash Flow: | $6.82B |
| Price / Cash Flow: | 20.54 |
| Annual Sales: | $16.27 |
| Price / Book: | 6.53 |
Profitability
| EPS (TTM): | 1.80000 |
|---|---|
| Net Income (TTM): | $4.61B |
| Gross Margin: | $41.87B |
| Return on Equity: | 10.61% |
| Return on Assets: | 4.31% |
Merck & Earnings Forecast
Key Merck & Financial Ratios
- The Gross Profit Margin over the past 39 years for MRK is 70.63%.
- The Selling, General & Administrative Expenses for MRK have been equal to 16.94% of Gross Profit Margin.
- The Research & Development expenses have been 22.85% of Revenue.
- The Interest Expense is 6.63% of Operating Income.
- The Net Earning history of MRK is 24.49% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 24 years.
Merck & Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Drug Manufacturers - General |
| Sector: | Healthcare |
| Current Symbol: | MRK |
| CUSIP: | 58933Y |
| Website: | merck.com |
Debt
| Debt-to-Equity Ratio: | 0.85 |
|---|---|
| Current Ratio: | 1.38 |
| Quick Ratio: | 0.83 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.6 |
|---|---|
| Forward P/E Ratio: | 12.58 |